chromium nicotinate

3-pyridinecarboxylic acid, chromium(2+) salt (2:1)

CAS: 148485-19-9 C12 H8 Cr N2 O4 MW: 296.20266000

Identification

Namechromium nicotinate
IUPACchromium(2+); pyridine-3-carboxylate
CAS Number148485-19-9
FDA UNIISearch
Molecular FormulaC12 H8 Cr N2 O4
Molecular Weight296.20266000
Nikkaji NumberJ2.877.404D

Regulatory

Physical Properties

Appearance grey-purple powder (est)
Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 292.00 to 293.00 °C. @ 760.00 mm Hg (est)
Vapor Pressure 0.000836 mmHg @ 25.00 °C. (est)
Flash Point 267.00 °F. TCC ( 130.70 °C. ) (est)
logP (o/w) 0.147 (est)

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorynutrient supplements, EFSA concludes: use is of safety concern.
Recommendation for chromium nicotinate usage levels up tonot for fragrance use.
Recommendation for chromium nicotinate flavor usage levels up tonot for flavor use.

Chemical sources Association Inc

Exchange of knowledge

Need This Item for Flavor? You can contact the Chemical Sources Association.

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

chromium dinicotinate chromium polynicotinate chromium(2+) dinicotinate chromium(2+); pyridine-3-carboxylate 3- pyridinecarboxylic acid, chromium(2+) salt (2:1) PubMed: Organoselenium Small Molecules and Chromium(III) Complexes for Intervention in Chronic Low-grade Inflammation and Type 2 Diabetes. PubMed: Hypoglycemic activity and acute oral toxicity of chromium methionine complexes in mice. PubMed: Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes. PubMed: In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial. PubMed: Mass spectrometric and spectroscopic studies of the nutritional supplement chromium(III) nicotinate. PubMed: Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes. PubMed: HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults. PubMed: Alteration of body composition in rats: effect of organic chromium and L-carnitine. PubMed: Effects of chromium nicotinate on performance, carcase characteristics and blood chemistry of growing turkeys. PubMed: Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. PubMed: Chromium and exercise training: effect on obese women. PubMed: Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. PubMed: Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. PubMed: Effects of chromium and guar on sugar-induced hypertension in rats. PubMed: Chromium picolinate increases membrane fluidity and rate of insulin internalization.